GENE ONLINE|News &
Opinion
Blog

COVID-19
COVID-19 FDA
FDA Approves Both Moderna’s and Pfizer/BioNTech’s Omicron Bivalent Vaccines in One Day
2022-08-31
COVID-19 AstraZenca
AstraZeneca’s Role in COVID-19 Slows Down as World Looks to mRNA Vaccines
2022-08-31
COVID-19 Moderna
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
COVID-19 Lawsuit
Moderna’s Lawsuit Against Pfizer/BioNTech: What Does This Mean for Their Vaccine’s future?
2022-08-26
COVID-19 FDA
FDA Removes N95 Respirators From the Medical Device Shortage List
2022-08-26
COVID-19 Moderna
Moderna Follows Pfizer With Their Own Omicron BA.4/BA.5 Application to the FDA
2022-08-24
COVID-19 Pfizer/BioNTech
Pfizer-BioNTech COVID-19 Vaccine Proven Effective in Young Children
2022-08-23
COVID-19 Pfizer/BioNTech
Pfizer and BioNTech’s New Bivalent Omicron Vaccine Lined Up for Authorization from the FDA
2022-08-22
COVID-19 Vaccine
EMA Begins Review of SK biosciences’ New Non-mRNA COVID-19 vaccine
2022-08-18
COVID-19 AstraZeneca
Despite Global Acceptance, The UK Refuses to Buy AstraZeneca’s Evusheld, Citing ‘Insufficient Data’
2022-08-16
COVID-19 SARS-CoV-2
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
COVID-19 mRNA Vaccine
MHRA Grants Moderna’s Omicron Bivalent Vaccine Conditional Approval in UK
2022-08-15
COVID-19 Antisense Oligonucleotides
Novel Inhalable COVID-19 Therapeutic Targeting Viral Replication
2022-08-10
COVID-19 COVID-19 VaccineModerna
European Commision Purchases an additional 15 million Moderna Bivalent COVID-19 Vaccines
2022-08-09
COVID-19 Moderna
Moderna to Supply 66 Million COVID-19 Boosters to US
2022-07-29
1 2 3 4 … 25
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top